ACRS vs GEN · rev $3.6M vs P/E 17, rev $5.00B
Aclaris Therapeutics Inc (ACRS) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
ACRS currently screens at market cap $615.9M. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the ACRS and GEN stock pages for the full models.
Not investment advice.